MARKET WIREReuters • 2h ago
Oil slips more than 1% as talks continue on ending Iran war - ReutersOil slips more than 1% as talks continue on ending Iran war Reuters
Why EVH Stock slipped -1.85% Today — RQD Quant Desk Flash
$4.25 -1.85% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $4.23
Evolent Health Inc (Class A) (EVH) carries a Roarable Rating of D- (Sell) with 35/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D- • RED ALERT
Cap $480.5M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on EVH Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is EVH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-01, Evolent Health Inc (Class A) (NYSE: EVH) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 35/100 at a spot price of $4.25 (-1.85% 1D, market cap $480.5M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 5/20, Executive Insider Alignment 6/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 9/20. Across 1011 tracked Consumer Discretionary issuers, EVH ranks #900 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does EVH compare to BLW and CSV in the Consumer Discretionary sector?
▼
Within the Consumer Discretionary sector (Other Consumer Services), EVH carries a Roarable D- (35/100 RQD), trailing P/E of N/A, gross margin of 21.3%, and ROIC of -26.3%. By comparison, BLW (Blackrock Limited Duration Income Trust) holds a D+ grade (52/100 RQD, P/E N/A, ROIC —, cap $415.0M) and CSV (Carriage Services Inc.) posts a C grade (64/100 RQD, P/E 10.9x, ROIC 29.8%, cap $562.9M). Among the 5-stock peer group, CSV leads on earnings multiple (10.9x) while CSV leads on capital efficiency (29.8% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for EVH?
▼
Per EVH's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001628908), Evolent Health Inc (Class A) generated $1.88B in revenue (-26.6% YoY), -$579.4M in net income, and $38.8M in free cash flow against $1.90B in total assets and $970.5M in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $4.23 (-0.52%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 8/20 (D-) • 2.1% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (35/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-8.5% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • D-
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D- · Rk E
Each axis scored 0–20
12M PRICE TARGET CONE-10.4% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for EVH)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (35/100 Composite)
🔍 WHY EVH SCORES 35/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Insider Conviction & Share Dilution+9/20 pts (26% of score)
SEC Form 4 / 13F Thermometer: 45% Net Buy • Disciplined Float (-0.40% YoY Shares)
▲ #2 Bullish Driver: Cash Engine Quality+8/20 pts (23% of score)
SEC XBRL FY 2025 (10-K): 2.1% FCF Margin ($38.8M FCF) & 21.3% Gross Margin
▼ #1 Drag / Risk Factor: Whale & Options Positioning5/20 pts (-15 pt drag)
Put hedging (50% put share) caps near-term gamma upside (-15 pts vs max)
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade E$4.04+13.1% Next Q
27
Q2 (-2Q)Grade E$4.57+5% Next Q
30
Q3 (-1Q)Grade E$4.80-11.5% Next Q
32
CurrentGrade D-$4.25-8.5% Hist 90D α
35
Trajectory: E (27) → D- (35)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a EVH Turnaround Squeeze
While EVH currently carries a cautious 35/100 (D-) rating due to Whale & Options Positioning (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Consumer Discretionary with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($4.20) and Max Pain ($4.46) forces dealer call-delta covering toward $7.23.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Disciplined Float (-0.40% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $EVH• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “EVH Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why EVH Stock slipped -1.85% Today — RQD Quant Desk Flash
Evolent Health Inc (Class A) (EVH) slipped -1.85% to $4.25, trading at 45% of its 52-week range ($2.1 – $6.89). Stretched risk/reward at current multiples (-26% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 45% of its 52-week range ($2.1 – $6.89) with RSI-14 at 49.2 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $4.25 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D- (Sell) backed by 21.3% gross margin and $38.8M annual free cash flow.
Live EVH Headlines & Catalysts
MARKET WIREReuters • 3h ago
Nine people dead in Learjet crash in south Florida, officials say - ReutersNine people dead in Learjet crash in south Florida, officials say Reuters
MARKET WIREReuters • 5h ago
Iran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz - ReutersIran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz Reuters
MARKET WIRECNBC • 7h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
MARKET WIRECNBC • 7h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 8h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 9h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 10h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring EVH)
- ✓Walkthrough of EVH's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
EVH // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +13.33%▲ ASCENDING CHANNEL
2026-10-30O $4.26H $4.31L $4.09C $4.25VOL 1.15M
RES: $5.14SUP: $3.49SMA50: $4.20SMA200: $3.87
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
EVH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. -26.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on EVH today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for EVH. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for EVH today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (EVH)
Consumer Discretionary Rank #900 of 1011
⚔️ BLW vs EVH Full Matrix →
1. Head-to-Head Consumer Discretionary Peer Comparison (EVH vs. BLW, CSV, EVI, KLC)
Industry: Other Consumer Services (73 Tracked Issuers)Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, Evolent Health Inc (Class A) (EVH) ranks #900 by composite RQD confidence (35/100, grade D-) and #592 by equity capitalization ($480.5M). Within this direct 5-issuer industry benchmark cohort, CSV leads on earnings valuation at 10.9x trailing P/E, while CSV leads on capital efficiency and profitability with 29.8% ROIC and 35.1% gross margin. CSV currently holds the highest overall quantitative score in the immediate peer group at 64/100 (C) compared with EVH at 35/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| EVH
ACTIVE
Evolent Health Inc (Class A) | D- | 35/100 | — | 21.3% | -26.3% | -1.85% | $480.5M | Benchmark Subject |
| BLW Blackrock Limited Duration Income Trust | D+ | 52/100 | — | — | — | +0.78% | $415.0M | /blw-vs-evh → |
| CSV Carriage Services Inc. | C | 64/100 | 10.9x | 35.1% | 29.8% | -2.74% | $562.9M | /csv-vs-evh → |
| EVI EVI Industries Inc. | C- | 61/100 | 37.3x | 30.4% | 5.4% | +1.26% | $279.7M | /evi-vs-evh → |
| KLC KinderCare Learning Companies Inc. | D- | 40/100 | — | — | -1.0% | +5.13% | $243.0M | /klc-vs-evh → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001628908In its most recent audited fiscal period (FY2025, filed 2025-12-31), Evolent Health Inc (Class A) (EVH) reported GAAP revenue of $1.88B (-26.6% vs. FY2024 revenue of $2.55B , and -4.5% cumulative change since FY2023) , GAAP net income of -$579.4M, operating cash flow of $38.8M, and free cash flow of $38.8M (+107.0% YoY). On the balance sheet, EVH closed FY2025 with $1.90B in total assets against $970.5M in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 4/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $1.88B | -$579.4M | $38.8M | $38.8M | $1.90B | $970.5M |
| FY2024 (FY) | 2024-12-31 | $2.55B | -$93.5M | $18.8M | $18.8M | $2.54B | $490.5M |
| FY2023 (FY) | 2023-12-31 | $1.96B | -$142.3M | $142.6M | $142.6M | — | — |
3. EVH Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs EVH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Evolent Health Inc (Class A) (NYSE: EVH) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 35/100 at a spot price of $4.25 (-1.85% 1D, market cap $480.5M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 5/20, Executive Insider Alignment 6/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 9/20. Across 1011 tracked Consumer Discretionary issuers, EVH ranks #900 in composite RQD confidence.
How does EVH compare to BLW and CSV in the Consumer Discretionary sector?
Within the Consumer Discretionary sector (Other Consumer Services), EVH carries a Roarable D- (35/100 RQD), trailing P/E of N/A, gross margin of 21.3%, and ROIC of -26.3%. By comparison, BLW (Blackrock Limited Duration Income Trust) holds a D+ grade (52/100 RQD, P/E N/A, ROIC —, cap $415.0M) and CSV (Carriage Services Inc.) posts a C grade (64/100 RQD, P/E 10.9x, ROIC 29.8%, cap $562.9M). Among the 5-stock peer group, CSV leads on earnings multiple (10.9x) while CSV leads on capital efficiency (29.8% ROIC).
What are the biggest fundamental strengths and SEC risk factors for EVH?
Per EVH's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001628908), Evolent Health Inc (Class A) generated $1.88B in revenue (-26.6% YoY), -$579.4M in net income, and $38.8M in free cash flow against $1.90B in total assets and $970.5M in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is EVH trading relative to its 50-day, 200-day, and 52-week technical levels?
EVH last traded at $4.25 (-1.85% on volume of 1,302,471 shares), positioning the stock +1.19% above its 50-day simple moving average ($4.20) and +9.82% above its 200-day simple moving average ($3.87). Across its 52-week range of $2.10 to $6.89, EVH sits at the 44.9% percentile with a 14-day RSI of 49.2 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($3.72 to $4.78).
EVH Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is EVH stock moving today?
Why EVH Stock slipped -1.85% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-26% return on capital) under elevated 10-year interest-rate pressure.